CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Flatt, Justin W ^a   Fox, Tara L ^a   Makarova, Natalia ^b   Blackwell, Jerry L ^b   Dmitriev, Igor P ^c   Kashentseva, Elena A ^c   Curiel, David T ^c   Stewart, Phoebe L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CAPSID PROTEIN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MEMBRANE PROXIMAL ECTODOMAIN REGION EPITOPE; MONOCLONAL ANTIBODY 2F5; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CONFORMATIONAL TRANSITION; CRYOELECTRON MICROSCOPY; IMMUNE RESPONSE; MOLECULAR DYNAMICS; STRUCTURE ANALYSIS; VIRUS CAPSID;

ADENOVIRIDAE; CAPSID PROTEINS; CRYOELECTRON MICROSCOPY; EPITOPES; GENETIC VECTORS; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP41; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY;

ADENOVIRIDAE; MIRIDAE;

EID: 84869134265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049607     Document Type: Article

References (34)

1. Plummer EM, Manchester M, (2010) Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3: 174-196.
2. Kawai T, Akira S, (2007) Antiviral signaling through pattern recognition receptors. J Biochem 141: 137-145.
3. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, et al. (1987) Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330: 381-384.
4. Kratz PA, Bottcher B, Nassal M, (1999) Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci U S A 96: 1915-1920.
5. Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, et al. (2007) A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 3: 1422-1431.
6. Hicks MJ, De BP, Rosenberg JB, Davidson JT, Moreno AY, et al. (2011) Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs. Mol Ther 19: 612-619.
7. Matthews QL, Fatima A, Tang Y, Perry BA, Tsuruta Y, et al. (2010) HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach. PLoS One 5: e11815.
8. Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, et al. (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 10: 1651-1658.
9. Schodel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, et al. (1992) The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol 66: 106-114.
10. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, et al. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 78: 10724-10737.
11. Cardoso RM, Brunel FM, Ferguson S, Zwick M, Burton DR, et al. (2007) Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. J Mol Biol 365: 1533-1544.
12. Ofek G, Guenaga FJ, (2010) Schief WR, Skinner J, Baker D, et al (2010) Elicitation of structure-specific antibodies by epitope scaffolds. Proc Natl Acad Sci U S A 107: 17880-17887.
13. Dai G, Steede NK, Landry SJ, (2001) Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120. J Biol Chem 276: 41913-41920.
14. Mirano-Bascos D, Tary-Lehmann M, Landry SJ, (2008) Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. Eur J Immunol 38: 1231-1237.
15. Kwong PD, Mascola JR, Nabel GJ, (2011) Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1. Cold Spring Harb Perspect Med 1: a007278.
16. van Heel M, Harauz G, Orlova EV, Schmidt R, Schatz M, (1996) A new generation of the IMAGIC image processing system. J Struct Biol 116: 17-24.
17. Mindell JA, Grigorieff N, (2003) Accurate determination of local defocus and specimen tilt in electron microscopy. J Struct Biol 142: 334-347.
18. Saban SD, Silvestry M, Nemerow GR, Stewart PL, (2006) Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol 80: 12049-12059.
19. Grigorieff N, (2007) FREALIGN: high-resolution refinement of single particle structures. J Struct Biol 157: 117-125.
20. Reddy VS, Natchiar SK, Stewart PL, Nemerow GR, (2010) Crystal structure of human adenovirus at 3.5 A resolution. Science 329: 1071-1075.
21. Meiler J, Baker D, (2003) Coupled prediction of protein secondary and tertiary structure. Proc Natl Acad Sci U S A 100: 12105-12110.
22. Karplus K, Barrett C, Hughey R, (1998) Hidden Markov models for detecting remote protein homologies. Bioinformatics 14: 846-856.
23. Jones DT, (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292: 195-202.
24. Guex N, Peitsch MC, (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
25. Liu J, Deng Y, Dey AK, Moore JP, Lu M, (2009) Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation. Biochemistry 48: 2915-2923.
26. Trabuco LG, Villa E, Mitra K, Frank J, Schulten K, (2008) Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. Structure 16: 673-683.
27. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26: 1781-1802.
28. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-38.
29. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
30. Matthews QL, Yang P, Wu Q, Belousova N, Rivera AA, et al. (2008) Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach. Virol J 5: 98.
31. Wu H, Han T, Belousova N, Krasnykh V, Kashentseva E, et al. (2005) Identification of sites in adenovirus hexon for foreign peptide incorporation. J Virol 79: 3382-3390.
32. Roberts DM, Nanda A, Havenga MJ, Abbink P, Lynch DM, et al. (2006) Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441: 239-243.
33. Liu H, Jin L, Koh SB, Atanasov I, Schein S, et al. (2010) Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 329: 1038-1043.
34. Sun ZY, Oh KJ, Kim M, Yu J, Brusic V, et al. (2008) HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28: 52-63.